(Q46145092)

19 December 2017

title

Radiation recall dermatitis induced by edatrexate in a patient with breast cancer (English)

1 reference

19 December 2017

Radiation Recall Dermatitis Induced by Edatrexate in a Patient with Breast Cancer (English)

1 reference

https://api.crossref.org/works/10.3109/07357909509024929

24 May 2024

author name string

E. A. Perez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7583710

24 May 2024

D. L. Campbell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7583710

24 May 2024

J. K. Ryu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7583710

24 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7583710

24 May 2024

publication date

1 January 1995

1 reference

19 December 2017

full work available at URL

http://www.tandfonline.com/doi/pdf/10.3109/07357909509024929

1 reference

https://api.crossref.org/works/10.3109/07357909509024929

24 May 2024

1 reference

19 December 2017

volume

13

1 reference

19 December 2017

issue

6

1 reference

19 December 2017

page(s)

604-607

1 reference

19 December 2017

A phase I trial of dactinomycin intravenous infusion in patients with advanced malignancies

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024929

Quantification of combined radiation therapy and chemotherapy effects on critical normal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024929

Radiation recall induced by tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024929

Toxic dermatitis induced by 10-ethyl-10-deaza-aminopterin (10-EdAM), a novel antifolate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024929

A phase I study of trimetrexate, an analog of methotrexate, administered monthly in the form of nine consecutive daily bolus injections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024929

Skin reactions induced by trimetrexate, an analog of methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024929

Radiation recall and radiosensitization with alkylating agents

21 January 2018

3

1 reference

https://api.crossref.org/works/10.3109/07357909509024929

Adriamycin-induced recall of radiation pneumonitis and epilation in lung and hair follicles of mouse

24 May 2024

4

1 reference

https://api.crossref.org/works/10.3109/07357909509024929

Radiation recall skin toxicity with bleomycin in a patient with kaposi sarcoma related to acquired immune deficiency syndrome

24 May 2024

5

1 reference

https://api.crossref.org/works/10.3109/07357909509024929

Radiation recall supraglottitis. A hazard in head and neck chemotherapy.

24 May 2024

6

1 reference

https://api.crossref.org/works/10.3109/07357909509024929

Radiation recall supraglottitis in a child

24 May 2024

7

1 reference

https://api.crossref.org/works/10.3109/07357909509024929

Cutaneous pathology following etoposide therapy

24 May 2024

8

1 reference

https://api.crossref.org/works/10.3109/07357909509024929

Taxol and radiation recall dermatitis

24 May 2024

10

1 reference

https://api.crossref.org/works/10.3109/07357909509024929

24 May 2024

Cancer Treatment Reports

12

69

551

Schmid F A

1985

1 reference

https://api.crossref.org/works/10.3109/07357909509024929

Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer

24 May 2024

14

1 reference

https://api.crossref.org/works/10.3109/07357909509024929

Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study

24 May 2024

16

1 reference

https://api.crossref.org/works/10.3109/07357909509024929

Cutaneous complications of chemotherapeutic agents

24 May 2024

17

1 reference

https://api.crossref.org/works/10.3109/07357909509024929

A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717

24 May 2024

20

1 reference

https://api.crossref.org/works/10.3109/07357909509024929

24 May 2024

Identifiers

1 reference

19 December 2017

1 reference

19 December 2017